| dc.contributor.author | Garcia-Ruiz, V.R. | |
| dc.contributor.author | Suarez-Rojas, J. | |
| dc.contributor.author | Alvarez-Gamero, J.C. | |
| dc.contributor.author | Somocurcio-Peralta, J.R. | |
| dc.contributor.author | Paz-Ibarra, J.L. | |
| dc.date.accessioned | 2025-10-31T18:35:47Z | |
| dc.date.available | 2025-10-31T18:35:47Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12805/5328 | |
| dc.description.abstract | Medullary thyroid cancer is a rare neuroendocrine tumor with ag-gressive behavior and an uncertain prognosis. Calcitonin is the associated tumor marker; however, neuroendocrine tumors of the lung or intestine can also present high values. We report the case of a 53-year-old patient presenting with dry cough for 3 years. Comput-ed tomography (CT) showed a 58-mm expansive lesion in the right anterior mediastinum and cervical ultrasound informed a 9-mm hypoechoic nodule with a lobulated edge and thick calcifications. Cytology reported Hashimoto’s thyroiditis. He underwent emergent surgery for respiratory failure. The pathological study informed G2 neuroendocrine carcinoma, immunohistochemistry showed: cytokeratin (+), vimentin (+), alpha-actin (-), synaptophysin (+), chromogranin (+), Ki-67: 10%. He progressed with bone metastasis visualized in scintigraphy and mediastinal tumor remnants, adenop-athy, and pulmonary nodules on CT scan, prompting chemotherapy. Due to elevated and increasing calcitonin, an ultrasound study with needle washout for calcitonin resulted in 1,724 pg/mL, and cytology of the nodule reported medullary carcinoma. He was finally diagnosed with medullary thyroid microcarcinoma with metastasis to the mediastinum. Coexistence with Hashimoto’s thyroiditis could alter the initial fine-needle aspiration results. We conclude that in the case of calcitonin-secreting neuroendocrine tumors or medullary thyroid cancer, calcitonin fine needle aspirate washout may be help-ful in elucidating a diagnosis. Due to its severity, medullary thyroid cancer should always be approached and managed aggressively, even microcarcinomas. | en_US |
| dc.format | application/pdf | |
| dc.language.iso | eng | |
| dc.publisher | Elmer Press | |
| dc.relation.ispartof | urn:issn:1923-2861 | |
| dc.rights | https://purl.org/coar/access_right/c_abf2 | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |
| dc.subject | SDG 3 | en_US |
| dc.subject | Thyroid Cancer Diagnosis and Treatment Innovations | en_US |
| dc.subject | Genetic and Clinical Insights into Medullary Thyroid Carcinoma | en_US |
| dc.title | Mediastinal Mass as First Clinical Manifestation of Medullary Thyroid Microcarcinoma in a Patient With Hashimoto’s Thyroiditis | en_US |
| dc.type | https://purl.org/coar/resource_type/c_2df8fbb1 | |
| dc.identifier.doi | https://doi.org/10.14740/jem841 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.27 | |
| dc.type.other | Research article | |
| dc.identifier.journal | Journal of Endocrinology and Metabolism | |
| dc.type.version | https://purl.org/coar/version/c_970fb48d4fbd8a85 | |